medigraphic.com
ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2010, Number S1

<< Back Next >>

Rev Mex Med Transfus 2010; 3 (S1)

Leishmaniasis and transfusion. Review article

Chongo AML, García ER

Language: Spanish
References: 15
Page: 42-47
PDF size: 159.80 Kb.


ABSTRACT

Leishmania is a protozoan parasite that causes leishmaniasis, a disease of varying clinical presentation and worldwide distribution. The World Health Organization considers a reemerging disease, uncontrolled, and their transmission patterns have been affected in recent years by human action, among others. Globally, the transmission vector is the most common. Other forms of transmission include parenteral, congenital, sexual, occupational, interpersonal. The transmission of leishmaniasis by blood transfusion remains a major problem in areas where kala-azar is endemic. The transfusiontransmitted leishmaniasis has been reported widely in many countries including India. For this to happen requires that the parasite is present in the peripheral blood of donors, preferably asymptomatic survive the process and storage in the blood bank, and infect the recipient.


REFERENCES

  1. Bañuls AL, Hide M, Prugnolle F. Leishmania and the Leishmaniases: A parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol 2007; 64: 1-109.

  2. Roberts LH. Leishmaniasis [Clinical review: Science, medicine, and the future]. British Medical Journal 2000; 321 (7264): 801-804.

  3. Sarman S. New developments in diagnosis of leishmaniasis. Indian J Med Res 2006; 123: 311-330.

  4. Dey A, Singh S. Transfusion transmitted leishmaniasis: A case report and review of literature. Indian J Med Microbiology 2006; 24 (3): 165-170.

  5. Flisser A, Pérez Tamayo R. Leishmaniasis. Aprendizaje de la parasitología basada en problemas. 2006; 41: 394-409.

  6. Proyecto de Modificación a la Norma Oficial Mexicana NOM- 032-SSA2-2002, Para la vigilancia epidemiológica, prevención y control de las enfermedades transmitidas por vector; para quedar como Norma Oficial Mexicana PROY-NOM-032- SSA2-2009 Para la vigilancia epidemiológica, prevención y control de las enfermedades transmitidas por vector.

  7. Ravel C, Cortes S, Pratloong F, Morio F, Dedet JP. First reports of genetic hybrids between two very divergent Leishmania species: Leishmania infantum and Leishmania major. Int J Parasitol 2006; 36: 1383-8.

  8. Scott P. Differentiation, regulation, and death of T helper cell subsets during infection with Leishmania major. Immunol Res 1998; 17: 229-38.

  9. Killick-Kendrick R. The biology and control of Phlebotomine sand flies. Clin Dermatol 1999; 17: 279-89.

  10. Handman E. Cell biology of Leishmania. Adv Parasitol 1999; 44: 1-39. Med Hyg 2004; 71: 71-2.

  11. Antoniou M, Doulgerakis C, Pratlong F, Dedet JP, Tselentis Y. Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum. Am J Trop Med Hyg 2004; 71: 71-2.

  12. Lawrence T, Goodnough MD, Mark E, Brecher MD, Kanter MH, Aubuchon JP. Transfusion Medicine-Blood Transfusion. N Engl J Med 1999; 340: 438-447.

  13. Beltrán CMC, Durán OP, Corredor ALF. La Leishmania spp. Como estrategia de diagnóstico y tratamiento de la leishmanisis, un artículo de revisión. Investig. Andina v.9 n.15 Pereira Jul./dez. 2007.

  14. Piscopo TV, Azzopardi CM. Leishmaniasis, Postgrad Med J 2007; 83: 649-57.

  15. Herwaldt BL. Leishmaniasis. Lancet 1999; 354 (9185): 1191-9.




2020     |     www.medigraphic.com